Process for preparing naloxone hydrochloride injection

A technology for preparation of injection and naloxone hydrochloride, applied in the field of medicine, can solve problems such as inability to prevent oxidative deterioration of products, and achieve the effects of preventing oxidative deterioration, reducing related substances and ensuring product quality

Inactive Publication Date: 2009-12-02
SHANDONG XINHUA PHARMA CO LTD
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But none of them can prevent the ox

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] The specification is 10ml: 4mg. By strictly controlling the pH range of 3.0-4.0 in the production, the pH can be kept unchanged during the placement process. At the same time, the method of inert gas protection is used in the production to reduce the oxygen content in the liquid medicine and the ampoule. To the minimum, prevent the oxidative deterioration of naloxone hydrochloride injection, and reduce related substances. Through the above two technologies, the product quality is greatly guaranteed.

Embodiment 2

[0013] The specification is 1ml: 1mg. By strictly controlling the pH range of 3.0-4.0 in the production, the pH can be kept unchanged during the placement process. At the same time, the method of inert gas protection is used in the production to reduce the oxygen content in the liquid medicine and the ampoule. To the minimum, prevent the oxidative deterioration of naloxone hydrochloride injection, and reduce related substances. Through the above two technologies, the product quality is greatly guaranteed.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a process for preparing naloxone hydrochloride injection. The pH of the naloxone hydrochloride injection can be unchangeable during placing by strictly controlling the pH range in production; and simultaneously, a method for inert gas protection adopted in the production reduces the oxygen content in liquid medicine and an ampoule to the minimum so as to prevent oxidative deterioration of the naloxone hydrochloride injection to reduce related substances. The technology greatly ensures the product quality.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular to a preparation process of naloxone hydrochloride injection. Background technique [0002] Naloxone hydrochloride is a pure opioid receptor antagonist with no intrinsic activity itself. However, it can competitively antagonize various opioid receptors and has a strong affinity for μ receptors. Naloxone takes effect quickly and has a strong antagonistic effect. Naloxone also reverses all effects of opioid agonists, including analgesia. In addition, it also has resuscitating effects that are not related to antagonizing opioid receptors. It can quickly reverse the respiratory depression caused by opioid analgesics, can cause high excitement, and make cardiovascular hyperfunction. Naloxone hydrochloride still has anti-shock effect. Morphine-like dependence, withdrawal symptoms and respiratory depression are not produced. [0003] Naloxone hydrochloride is currently the most wide...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/08A61K31/485A61P39/02A61P25/00
Inventor 李印秋
Owner SHANDONG XINHUA PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products